United States · FDA National Drug Code directory
RIZATRIPTAN BENZOATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72189-316_2c3d1d1c-309d-23dd-e063-6294a90ac2ef
- Product NDC
- 72189-316
- Form
- TABLET
- Composition / generic term
- RIZATRIPTAN BENZOATE
- Labeler
- Direct Rx
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220120
- Source listing expiry
- 20261231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 18 TABLET in 1 BOTTLE (72189-316-18) · 72189-316-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →